The lung microenvironment: an important regulator of tumour growth and metastasis

NK Altorki, GJ Markowitz, D Gao, JL Port… - Nature Reviews …, 2019 - nature.com
Lung cancer is a major global health problem, as it is the leading cause of cancer-related
deaths worldwide. Major advances in the identification of key mutational alterations have led …

[HTML][HTML] Natural therapeutics and nutraceuticals for lung diseases: traditional significance, phytochemistry, and pharmacology

MM Rahman, S Bibi, MS Rahaman, F Rahman… - Biomedicine & …, 2022 - Elsevier
Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …

Obesity and Lung Cancer (Investigating the Relationship)

N Tzenios - EPRA International Journal of Multidisciplinary …, 2023 - eprajournals.net
Obesity is a global issue, and it leads to various health comorbidities like cardiovascular
disease, diabetes type II and certain cancers. The relationship between obesity and cancer …

FAPI-74 PET/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients

FL Giesel, S Adeberg, M Syed, T Lindner… - Journal of Nuclear …, 2021 - Soc Nuclear Med
68 Ga-fibroblast activation protein inhibitors (FAPIs) 2, 4, and 46 have already been
proposed as promising PET tracers. However, the short half-life of 68 Ga (68 min) creates …

[HTML][HTML] The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles

MJ Sanaei, S Razi, A Pourbagheri-Sigaroodi… - Translational …, 2022 - Elsevier
Lung cancer is the leading cause of cancer-related mortality worldwide. Although the
PI3K/Akt/mTOR signaling pathway has recently been considered as one of the most altered …

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin

MG Oser, MJ Niederst, LV Sequist… - The Lancet …, 2015 - thelancet.com
Lung cancer is the most common cause of cancer deaths worldwide. The two broad
histological subtypes of lung cancer are small-cell lung cancer (SCLC), which is the cause of …

Immune cell composition in human non-small cell lung cancer

B Stankovic, HAK Bjørhovde, R Skarshaug… - Frontiers in …, 2019 - frontiersin.org
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death in the
world. Immunological analysis of the tumor microenvironment (immunoscore) shows great …

[HTML][HTML] The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer

RM Bremnes, LT Busund, TL Kilvær, S Andersen… - Journal of Thoracic …, 2016 - Elsevier
A malignant tumor is not merely an accumulation of neoplastic cells, but constitutes a
microenvironment containing endothelial cells, fibroblasts, structural components, and …

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a …

R Rosell, E Carcereny, R Gervais… - The lancet …, 2012 - thelancet.com
Background Erlotinib has been shown to improve progression-free survival compared with
chemotherapy when given as first-line treatment for Asian patients with non-small-cell lung …

USP14: structure, function, and target inhibition

F Wang, S Ning, B Yu, Y Wang - Frontiers in Pharmacology, 2022 - frontiersin.org
Ubiquitin-specific protease 14 (USP14), a deubiquitinating enzyme (DUB), is associated
with proteasomes and exerts a dual function in regulating protein degradation. USP14 …